Toscana Life Sciences
Emanuele Andreano earned his Bachelor of Science (B.Sc.) in Biotechnology from the University of Siena (Italy) in 2013. Afterward, he was awarded a LLP-Erasmus Placement scholarship at Newcastle University (UK) where he also obtained his Master's degree of Research (M.Res.) in Immunobiology (2015). In the Fall of 2015, Emanuele moved back to Siena where he started his Ph.D. with the University of Siena and Glaxo Smith Kline (GSK) Vaccines Siena (Italy) and Rockville, Maryland (USA) which he has been awarded in April of 2019. During this period he gained extensive experience on single-cell sorting of antigen-specific memory B cells and isolation, cloning, expression, and functional/structural characterization of human monoclonal antibodies. This experience has been used to unravel the functional antibody repertoire against the respiratory syncytial virus (RSV) fusion protein (F-protein) in healthy and vaccinated donors. Emanuele is currently a European Research Council (ERC) Post-Doctoral fellow within the research group led by Dr. Rino Rappuoli at Fondazione Toscana Life Sciences in Siena. Here, he works on the isolation of human monoclonal antibodies against viral and bacterial pathogens with a particular focus on SARS-CoV-2 and Neisseria gonorrhoeae. The aim of his Post-Doc is to fight global threats for human health such as emerging infectious diseases and antimicrobial resistance (AMR).